Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 6, 2019New England Journal of MedicineOpen Access

Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis

View Full Paper
Ask AI
Bookmark
Share

Authors

HBH. BachelezSCSiew Eng ChoonSMSlaheddine Marrakchi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bachelez et al. (2019) studied this question.

synapsesocial.com/papers/6a8a75759be9d02581bdb1edhttps://doi.org/10.1056/nejmc1811317
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis2011 · 992 citations
  2. 2Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies2017 · 85 citations
  3. 3European consensus statement on phenotypes of pustular psoriasis2017 · 449 citations